[1]
Uyaroğlu, O.A., Sönmezer, M.Ç., Telli Dizman, G., Çalık Başaran, N., Karahan, S. and Uzun, Ö. 2022. Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study. Acta Medica. 53, 1 (Mar. 2022), 73–82. DOI:https://doi.org/10.32552/2022.ActaMedica.719.